Effect of lipid dose on the biodistribution and blood pool clearance kinetics of PEG-modified technetium-labeled lipid vesicles

Journal of Liposome Research

Volumn 8, Issue 3, 1998, Pages 381-390

  Utkhede, Deepank R ^a   Tilcock, Colin P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Blood pool; Circulation half life; Imaging; Liposome; Polyethylene glycol; Technetium 99m

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DISTEAROYLPHOSPHATIDYLCHOLINE; LIPOSOME; TECHNETIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFECT; DRUG HALF LIFE; LIPID BILAYER; LIPID VESICLE; NONHUMAN; PRIORITY JOURNAL; RABBIT; TISSUE DISTRIBUTION;

EID: 0031684786     PISSN: 08982104     EISSN: None     Source Type: Journal    
DOI: 10.3109/08982109809035541     Document Type: Article

References (32)

1. Senior, J.H. 1987. Fate and behavior of liposomes in vivo: a review of controlling factors. CRC Crit Rev Ther Drug Carrier Syst 3:123-193.
2. Phillips, W.T., Rudolph, A.S., Goins, B. and Klipper, R. 1992. Biodistribution studies of liposome encapsulated hemoglobin (LEH) studies with newly developed 99m-technetium liposome label. Biomaterials, Artificial Cells and Immobilization Technology 20:757-760
3. Storm, G., Oussoren, C., Peeters, P.A.M. and Barenholz, Y. Tolerability of liposomes in vivo. in Liposome Technology, Volume III, Gregoriadis, G. (ed.), pp. 345-383, CRC Press, BocaRaton, FL. 1993.
4. Allen, T.M. and Hansen, C. 1991. Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochim Biophys Acta 1068:133-141
5. Woodle, M.C, and Lasic, D.D. 1992. Sterically-stabilized liposomes. Biochim Biophys Acta 113:171-199.
6. Papahajopoulos, D., Allen, T., Gabizon, A., Mayhew, E., Matthay, K., Huang, S.K., Woodle, M.C., Lasic, D.D., Redemann, C., and Martin, F.J. 1991. Sterically stabilized liposomes: significant improvements in blood clearance, tissue deposition and therapeutic index of encapsulated drugs against implanted tumors. Proc Natl Acad Sci USA 88:1460-11464.
7. Woodle, M.C. 1993. 67-Gallium-labeled liposomes with prolonged circulation: preparation and potential as nuclear imaging agents. J Nucl Med Biol 20:149-155.
8. Tilcock, C., Yap, M., Szucs, M., Utkhede, D. 1994. PEG-modified lipid vesicles with encapsulated technetium-99m as blood pool agents for nuclear medicine. J Nucl Med 21:165-170.
9. Goins, B., Phillips, W.T. and Klipper, R. 1996. Blood-pool imaging using technetium-99m-labeled liposomes. J Nucl Med 37:1374-1379.
10. Phillips, W.T., Rudolph, A.S., Goins, B., Timmons, J.H., Klipper, R., and Blumhardt,. R. 1992. A simple method for producing a technetium-99m-labeled liposome which is stable in vivo. J Nucl Med 19:539-547.
11. Tilcock, C., Ahkong, Q.F. and Fisher, D. 1994. 99mTc-labeling of lipid vesicles containing the lipophilic chelator PE-DTTA: effect of tin-to-chelate ratio, chelate content and surface polymer on labeling efficiency and biodistribution behavior. Nucl Med Biol 21:89-96.
12. Allen, T.M., Hansen, C., Martin, F., Redemann, C. and Yau-Young, A. 1991. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1066:29-36.
13. Litzinger, D.C. and Huang, L. 1992. Ampipathic poly(ethylene glycol) 5000-stabilized dioleoylphosphatidylethanolamine liposomes accumulate in the spleen. Biochim Biophys Acta 112:249-254.
14. Allen, T.M. and Papahadjopoulos, D. Sterically stabilized (stealth) liposomes: Pharmacokinetics and therapeutic advantages in Liposome Technology, Volume III, 2nd edition, Gregoriadis G. (ed.), pp. 59-72, CRC Press, Boca Raton, FL. 1992.
15. Zalipsky, S., Hansen, C.B., Oaks, J.M. and Allen, T. 1996. Evaluation of blood clearance rates and biodistribution of poly(2-oxazoline)-grafted liposomes. J Pharm Sci 85:133-137.
16. Torchilin, V.P., Trubetskoy, V.S., Whiteman, K,R., Caliceti, P., Ferruti, P. and Ver-onese, P.M. 1995. New synthetic amphiphilic polymers for steric protection of liposomes in vivo. J Pharm Sci 84:1049-1053.
17. Torchilin, V.P., Omelyanenko, V.G., Papisov, M.I., Bogdanov, A.A., Trubetskoy, V.S., Herron, J.N. and Gentry, C.A. 1994. Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer coated longevity. Biochim Biophys Acta 1195:11-20.
18. Needham, D., McIntosh, T.J. and Lasic, D.D. 1992. Repulsive interactions and mechanical stability of polymer-grafted lipid membranes. Biochim Biophys Acta 1108:40-48.
19. Blume, G. and Cevc, G. 1993. Molecular mechanism of the lipid vesicle longevity in vivo. Biochim Biophys Acta 1146:157-168.
20. Liu, D., Song, Y.K. and Liu, F. 1995 Antibody dependent, complement mediated liver uptake of liposomes containing GM1. J Pharm Res 12:1775-1780.
21. Harashima, H., Sakata, K., Funato, K. and Kiwada, H. 1994. Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes. J Pharm Res 11:402-406.
22. Liu, D., Liu, F. and Song, Y.K. 1995. Recognition and clearance of liposomes containing phospatidylserine are mediated by serum opsonins. Biochim Biophys Acta 140-146.
23. Liu ,F. and Liu, D. 1996. Serum independent liposome uptake by mouse liver. Biochim Biophys Acta 1278:5-11.
24. Liu, D., Hu, Q. and Song, Y.K. 1995. Liposome clearance from blood: different animal species have different mechanisms. Biochim Biophys Acta. 1240:277-284.
25. Marjan, J., Xie, Z. and Devine, D. 1994. Liposome-induced activation of the classical complement pathway does not require immunoglobins. Biochim Biophys Acta 1192:35-44.
26. Oja, C.D., Semple, S.C., Chonn, A. and Cullis, P.R. 1996. Influence of dose on liposome clearance: critical role of blood proteins. Biochim Biophys Acta 1281:31-37.
27. Harashima, H., Sakata, K. and Kiwada, H. 1993. Distinction between the depletion of opsonins and the saturation of uptake in the dose-dependent hepatic uptake of liposomes. J Pharm Res 10:606-610.
28. Devine, D.V., Wong, K., Serrano, K., Chonn, A. and Cullis P.R. 1994. Liposome-complement interactions in rat serum: implications for liposome survival studies. Biochim Biophys Acta 1191:43-51.
29. Allen, T.M., Hansen, C and Rutledge, J. 1989. Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. Biochim Biophys Acta 981:27-35.
30. Chilton, H.M. and Brown, M.L. Radiopharmaceuticals for abdominal and gastrointestinal imaging: reticuloendothelial, hepatobiliary, and intestinal in Pharmaceuticals in Medical Imaging. Swanson, D.P, Chilton, H.M and Thrall, J.H. (eds.), pp. 462-500, Macmillan Publishing Co., Inc., New York. 1990.
31. Adalet, I. and Cantez, S. 1994. Poor-quality red blood cell labeling with technetium-99m: case report and review of the literature. Eur J Nucl Med 212:173-175.
32. Hambye, A.S., Vandermeiren, R., Vervaet, A. and Vandevivere, J. 1995. Failure to label red blood cells adequately in daily practice using an in vivo method: methodological and clinical considerations. Eur J Nucl Med. 22:61-76.